Bavarian Nordic IP Suit Over Cancer Vaccine Lives
A judge has rejected Oxford Biomedica PLC's effort to jettison Bavarian Nordic A/S' amended complaint in a patent infringement suit over Oxford Biomedica's experimental cancer vaccine TroVax....To view the full article, register now.
Already a subscriber? Click here to view full article